Callan Capital’s Goldman Sachs ActiveBeta Emerging Markets Equity ETF GEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.31M Sell
99,619
-1,114
-1% -$36.7K 0.24% 59
2024
Q4
$3.22M Buy
100,733
+254
+0.3% +$8.61K 0.24% 58
2024
Q3
$3.53M Sell
100,479
-4,717
-4% -$156K 0.25% 59
2024
Q2
$3.44M Sell
105,196
-9,372
-8% -$300K 0.28% 59
2024
Q1
$3.59M Sell
114,568
-1,576
-1% -$48K 0.32% 52
2023
Q4
$3.56M Sell
116,144
-7,174
-6% -$209K 0.34% 48
2023
Q3
$3.53M Sell
123,318
-8,844
-7% -$264K 0.38% 50
2023
Q2
$3.95M Sell
132,162
-89,023
-40% -$2.65M 0.44% 46
2023
Q1
$6.58M Sell
221,185
-2,368
-1% -$70.7K 0.76% 27
2022
Q4
$6.33M Sell
223,553
-10,375
-4% -$284K 0.78% 28
2022
Q3
$6.04M Sell
233,928
-45,475
-16% -$1.31M 0.98% 22
2022
Q2
$8.31M Buy
279,403
+81,254
+41% +$2.56M 1.28% 19
2022
Q1
$6.71M Sell
198,149
-7,698
-4% -$274K 0.92% 24
2021
Q4
$7.62M Sell
205,847
-1,900
-0.9% -$70.5K 1.11% 18
2021
Q3
$7.71M Buy
207,747
+15,515
+8% +$603K 1.28% 16
2021
Q2
$7.84M Buy
192,232
+6,387
+3% +$258K 1.36% 16
2021
Q1
$7.34M Buy
185,845
+15,839
+9% +$635K 1.33% 16
2020
Q4
$6.49M Buy
170,006
+6,185
+4% +$219K 1.32% 16
2020
Q3
$5.37M Buy
163,821
+23,830
+17% +$785K 1.21% 19
2020
Q2
$4.24M Sell
139,991
-133,023
-49% -$3.81M 1.06% 18
2020
Q1
$7.14M Sell
273,014
-2,765
-1% -$87.1K 2.2% 11
2019
Q4
$9.47M Buy
275,779
+23,466
+9% +$770K 2.6% 9
2019
Q3
$7.91M Buy
+252,313
New +$8.04M 2.27% 9

Other funds holding GEM

Callan Capital's GEM Position: Q1 2025 in Review

Callan Capital reduced its Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) stake by 1.1% in Q1 2025, selling an estimated $36.7K and leaving 99,619 shares worth $3.31M. The position accounts for 0.24% of the portfolio, ranked #59.

Callan Capital first reported a position in GEM in Q3 2019 and has held it in 23 quarters since. The position peaked at $9.47M in Q4 2019. 150 funds tracked by Wall St. Rank hold GEM as of Q1 2025.

  • Callan Capital held 99,619 shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF worth $3.31M as of Q1 2025.
  • Callan Capital sold 1,114 Goldman Sachs ActiveBeta Emerging Markets Equity ETF shares in Q1 2025, an estimated $36.7K.
  • Goldman Sachs ActiveBeta Emerging Markets Equity ETF made up 0.24% of Callan Capital's portfolio in Q1 2025, its #59 holding.
  • Callan Capital first reported a position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF in Q3 2019 and has held it in 23 quarters since.
  • Callan Capital's Goldman Sachs ActiveBeta Emerging Markets Equity ETF position peaked at $9.47M in Q4 2019.
  • 150 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta Emerging Markets Equity ETF as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.